Getinge completes its recommended cash offer for Huntleigh

Getinge Extended Care UK Limited, a wholly owned subsidiary of Getinge AB (publ), on 8 December 2006 announced a recommended cash offer for all of the outstanding share capital of Huntleigh Technology PLC.

Getinge has now acquired, or received valid acceptances of the offer in respect of 81,702,698 Huntleigh shares, representing in aggregate approximately 95.8% of all shares in Huntleigh. Further, all other remaining conditions to the offer have now either been satisfied or waived.

Accordingly, the offer is declared unconditional in all respects.

Getinge has also decided to extend the offer, which remains open for acceptances until 3:00 p.m. on 17 January 2007.

Getinge will procure that Huntleigh is delisted and that the trading on the London Stock Exchange ceases, which is anticipated to take effect on 1 February 2007.

As the owner of more than 90 per cent. of the shares and votes in Huntleigh, Getinge will use its right to acquire compulsorily the remaining Huntleigh shares on the same terms as the offer.

For further information concerning the completion of the offer regarding e.g. settlement, further acceptances as well as the forthcoming process, please refer to the UK press releases pertaining to the completion of the offer, which are released today (see Unconditional as to acceptances/Unconditional in all respects)


Getinge AB
Johan Malmquist
Ulf Grunander

Tel: +46 35 15 55 00

UBS Investment Bank
(financial adviser to Getinge)

Henry Elphick
Benjamin Lee

Tel: +44 (0) 20 7567 8000

About Us

Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving the every-day life for people, today and tomorrow.


Documents & Links